Heron Therapeutics Inc (HRTX:NASDAQ) Annual Reports & Investor Relations Material

Overview

Heron Therapeutics, Inc., a biotech firm focused on developing treatments for unmet patient needs, has been making strides in the field with its proprietary Biochronomer drug delivery technology. This technology allows for the administration of short-acting pharmacological agents with a single dosage that lasts for days to weeks. Its product offerings include SUSTOL, an extended-release injection for the prevention of nausea and vomiting associated with chemotherapy, as well as CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist that also helps with chemotherapy-induced sickness. Additionally, Heron is developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. Its investigational agents, HTX-019 and HTX-034, target postoperative nausea and vomiting and postoperative pain management, respectively. With its headquarters in San Diego, California, Heron Therapeutics began as A.P. Pharma, Inc. in 1983 and rebranded as Heron Therapeutics, Inc. in January 2014.

Frequently Asked Questions

What is Heron Therapeutics Inc's ticker?

Heron Therapeutics Inc's ticker is HRTX

What exchange is Heron Therapeutics Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Heron Therapeutics Inc's headquarters?

They are based in San Diego, California

How many employees does Heron Therapeutics Inc have?

There are 51-200 employees working at Heron Therapeutics Inc

What is Heron Therapeutics Inc's website?

It is herontx.com

What type of sector is Heron Therapeutics Inc?

Heron Therapeutics Inc is in the Healthcare sector

What type of industry is Heron Therapeutics Inc?

Heron Therapeutics Inc is in the Drug Manufacturers - Other industry

Who are Heron Therapeutics Inc's peers and competitors?

The following five companies are Heron Therapeutics Inc's industry peers:

- Harrow Health

- The Flowr Corporation

- PetIQ

- Regenerx Biopharmaceuticals Inc.

- Neoleukin Therapeutics